We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Marechale Capital Plc | LSE:MAC | London | Ordinary Share | GB0005401087 | ORD 0.8P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 1.45 | 1.40 | 1.50 | 1.45 | 1.45 | 1.45 | 0.00 | 07:49:27 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Investment Advice | 669k | -183k | -0.0017 | -8.53 | 1.54M |
From Jan 2023 to Jan 2025
20 February 2023
Marechale Capital plc
(“Marechale” or the “Company”)
Realisation of Investment
The Directors of Marechale Capital plc (AIM: MAC) announce that the Company has received proceeds of £218,000 for the sale of shares held in Future Biogas Group Ltd (“FBG”), following the acquisition of FBG by 3i Infrastructure plc on 15 February 2023. The shares sold in FBG included shares that were originally acquired in 2010-11 for £11,600 and shares issued to the Company by FBG in exchange for warrants granted to the Company as a result of its advice and assistance in fundraising.
The realisation of this investment is an example of the fulfilment of the Company’s strategy to have equity in its growth company clients, as part of its corporate finance fees.
The Company’s investments are held according to IFRS 9 at ‘fair value’ and any profits and/or losses recognised through the Profit and Loss Account. While the Company will record a small loss from the sale of the shares in the current financial year, over the 12 years since the initial investments in FBG, Marechale has recorded total net gains of £206,000. The proceeds of the sale have been received in full, in cash and will help provide working capital for the group as the markets remain challenging for fundraising, as was reported on in the Company’s half-yearly results announced on 2 December 2022.
This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.
For further information please contact:
| Marechale Capital plc Mark Warde-Norbury / Patrick Booth-Clibborn |
Tel: +44 (0)20 7628 5582 |
| Cairn Financial Advisers LLP (Nomad) Jo Turner / Sandy Jamieson |
Tel: +44 (0)20 7213 0880 |
| BlytheRay (Financial PR) Tim Blythe / Megan Ray |
Tel: + 44 (0)78 7574 4070 marechalecapital@blytheray.com |
About Marechale Capital
Marechale is an established City of London based corporate finance house, with a long-term track record and a strong reputation in advising & financing high growth consumer brands, leisure, clean energy, and technology companies. The Company uses its balance sheet to co-invest in its client companies, along with warrants and founder equity, in order to create shareholder value.
Copyright y 17 PR Newswire
1 Year Marechale Capital Chart |
1 Month Marechale Capital Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
